variety
of
genetic
immune
disorders
For
example,
NIAID
scientist
S Con
developed
a
lentivira
1 gene
therapy
to treat
infants
with X-
SCID, a
rare and
fatal
genetic
immune
deficienc
y. In
clinical
trials,
the gene
therapy
successfu
lly
restored
the
immune
systems
of
infants

newly
diagnosed
with X-
SCID, as
well as
older
children
and young
adults
with the

NIH-001402
